Emergency Use Authorization of Relenza (zanamivir)
April 29, 2009 1:45 AM ET
Fact sheet for health care providers 
[PDF 25.9KB] Apr 27, 2009
Fact Sheet for Patients and Parents [PDF 25.3KB] Apr 27, 2009
Patient instructions for Diskhaler
Package insert [PDF 222KB]
EUA conditions for state and local partners Apr 27, 2009
***Note: For information on recognizing and reporting adverse events (side effects) of Relenza, please refer to the applicable Fact Sheet.
- Links to non-federal organizations are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the federal government, and none should be inferred. CDC is not responsible for the content of the individual organization Web pages found at these links.
Get email updates
To receive daily email updates about this site, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348
24 Hours/Every Day - cdcinfo@cdc.gov
